Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depsipeptide in Advanced Transitional Cell Carcinoma
NCT00087295Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Jun 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of romidepsin in transitional cell carcinoma (TCC), sponsored by SWOG Cancer Research Network. Started Jun 2004; status: terminated.
02
Drugs
romidepsin
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00087295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087295.